Skip to main content

Advertisement

Log in

Large Apical Thrombus in a Patient with Persistent Heart Failure and Hypereosinophilia: Löffler Endocarditis

  • Case Reports/Clinical Vignettes
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Idiopathic hypereosinophilic syndrome is an uncommon leukoproliferative systemic disorder characterized by the overproduction of eosinophils and poor prognosis. A major source of morbidity and mortality of this syndrome is the associated cardiac involvement represented by endocardial thickening and mural thrombi. We report a 64-year-old woman with persistent symptoms of heart failure despite standard medical therapy. Echocardiography revealed reduced left ventricular filling due to a large apical mass; an abnormal diastolic filling pattern was also noticed. Complete blood count revealed remarkable hypereosinophilia. Cardiac magnetic resonance imaging demonstrated an apical thrombus and intense linear enhancement of the endocardium, which were compatible with Löffler endocarditis. Medical therapy, including corticosteroids and anticoagulation, was initiated promptly. The symptoms improved as the peripheral hypereosinophilia resolved in 15 days. The patient was asymptomatic at the 1-year follow-up visit with complete regression of the apical thrombus and no evidence of restrictive cardiomyopathy. We report this case to draw attention to this particularly rare condition with poor prognosis since quick and accurate diagnosis and prompt initiation of therapy may improve symptoms and survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Loffler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein cigenartiges Krankheitsbid. Schweiz Med Wochenscher. 1936;66:817–20.

    Google Scholar 

  2. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med. 1968;68:1220–9.

    PubMed  CAS  Google Scholar 

  3. Fujimura J, Murakami Y, Tsuda A, Chiba T, Migita M, Fukunaga Y. A neonate with Löffler syndrome. J Perinatol. 2001;21:207–8.

    Article  PubMed  CAS  Google Scholar 

  4. Nakagawa M, Hamaoka K. Myocardial thickening in children with acute myocarditis. Chest. 1993;104:1676–8.

    Article  PubMed  CAS  Google Scholar 

  5. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of 14 cases with review of the literature. Medicine (Baltimore). 1975;54:1–27.

    Article  CAS  Google Scholar 

  6. Corssmit EP, Trip MD, Durrer JD. Löffler’s endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology. 1999;91:272–6.

    Article  PubMed  CAS  Google Scholar 

  7. Solley GO, Maldonado JE, Gleich GJ, et al. Endomyocardiopathy with eosinophilia. Mayo Clin Proc. 1976;51:697–708.

    PubMed  CAS  Google Scholar 

  8. Child JS, Perloff JK. The restrictive cardiomyopathies. Cardiol Clin. 1988;6:289–316.

    PubMed  CAS  Google Scholar 

  9. Spry CJ, Take M, Tai PC. Eosinophilic disorders affecting the myocardium and endocardium: a review. Heart Vessels Suppl. 1985;1:240–2.

    Article  PubMed  CAS  Google Scholar 

  10. Baratta L, Afeltra A, Delfino M, De Castro S, Giorgino F, Rossi-Fanelli F. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy—case report and literature review. Angiology. 2002;53:465–70.

    Article  PubMed  Google Scholar 

  11. Tefferi A. Modern diagnosis and treatment of primary eosinophilia. Acta Haematol. 2005;114:52–60.

    Article  PubMed  CAS  Google Scholar 

  12. Pardanani A, Brockman SR, Paternoster SF, et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood. 2004;104:3038–45.

    Article  PubMed  CAS  Google Scholar 

  13. Wilkins HJ, Crane MM, Copeland K, Williams WV. Hypereosinophilic syndrome: an update. Am J Hematol. 2005;80:148–57.

    Article  PubMed  Google Scholar 

  14. Karnak D, Kayacan O, Beder S, Delibalta M. Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ. 2003;168:172–5.

    PubMed  Google Scholar 

  15. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651–63.

    Article  PubMed  CAS  Google Scholar 

  16. Hagendorff A, Hümmelgen M, Omran H, et al. Löffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia. Z Kardiol. 1998;87:293–9.

    PubMed  CAS  Google Scholar 

  17. Shabetai R. Restrictive, obliterative, and infiltrative cardiomyopathies. In: Alexander RW, Schlant RC, Fuster V, ed. Hurst’s the Heart. McGraw-Hill. 1998:2085–6.

  18. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97:78–92.

    PubMed  CAS  Google Scholar 

  19. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83:2759–79.

    PubMed  CAS  Google Scholar 

  20. Bozcali E, Aliyev F, Agac MT, et al. Unusual case of aortic valve involvement in patient with Löffler’s Endomyocarditis: management, follow-up and short review of the literature. J Thromb Thrombolysis. 2007;24:309–13.

    Article  PubMed  Google Scholar 

  21. Seward J, Tajik AJ. Restrictive cardiomyopathy. Curr Opin Cardiol. 1987;2:488–501.

    Article  Google Scholar 

  22. Gotlib J, Cools J, Malone JM 3rd, Schrier SL, Gilliland DG, Coutré SE. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood. 2004;103:2879–91.

    Article  PubMed  CAS  Google Scholar 

  23. Constantine G, Shan K, Flamm SD, Sivananthan MU. Role of MRI in clinical cardiology. Lancet. 2004;363:2162–71.

    Article  PubMed  Google Scholar 

  24. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation. 2004;109:1328–34.

    Article  PubMed  Google Scholar 

  25. Salanitri GC. Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. Am J Roentgenol. 2005;184:1432–3.

    Google Scholar 

  26. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol. 2000;86:110–3.

    Article  PubMed  CAS  Google Scholar 

  27. Roufosse F, Bartholomé E, Schandené L, Goldman M, Cogan E. The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies. Drugs Today (Barc). 1998;34:361–73.

    CAS  Google Scholar 

  28. Lefebvre C, Bletry O, Degoulet P, et al. Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris). 1989;140:253–7.

    CAS  Google Scholar 

  29. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997;336:267–76.

    Article  PubMed  CAS  Google Scholar 

  30. Wynn SR, Sachs MI, Keating MU, et al. Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant. J Pediatr. 1987;111:94–7.

    Article  PubMed  CAS  Google Scholar 

  31. Morton RL, Shoemaker LR, Eid NS. Steroid-refractory neonatal eosinophilic pneumonia responsive to cyclosporin A. Am J Respir Crit Care Med. 1999;160:1019–22.

    PubMed  CAS  Google Scholar 

  32. Schaller JL, Burkland GA. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. MedGenMed. 2001;3:9.

    PubMed  CAS  Google Scholar 

  33. Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004;113:115–9.

    Article  PubMed  CAS  Google Scholar 

  34. Baccarani M, Cilloni D, Rondoni M, et al. The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Haematologica. 2007;92:1173–9.

    Article  PubMed  CAS  Google Scholar 

  35. Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, Moraes CR. Surgery for endomyocardial fibrosis revisited. Eur J Cardiothorac Surg. 1999;15:309–12.

    Article  PubMed  CAS  Google Scholar 

  36. Lengyel M, Dekov E. Two-dimensional echocardiographic features of Löffler’s endocarditis. Acta Cardiol. 1982;37:59–69.

    PubMed  CAS  Google Scholar 

  37. Schneider U, Jenni R, Turina J, Turina M, Hess OM. Long-term follow-up of patients with endomyocardial fibrosis: effects of surgery. Heart. 1998;79:362–7.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No funding or grant was received.

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beste Ozben MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cincin, A.A., Ozben, B., Tanrikulu, M.A. et al. Large Apical Thrombus in a Patient with Persistent Heart Failure and Hypereosinophilia: Löffler Endocarditis. J GEN INTERN MED 23, 1713–1718 (2008). https://doi.org/10.1007/s11606-008-0705-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-008-0705-y

KEY WORDS

Navigation